{
  "identification": {
    "trialId": "METC 04",
    "open": true,
    "acronym": "TEDR1",
    "title": "TEDR1 Trial: A phase II trial to evaluate efficacy of specific EGFR inhibitors in lung cancer",
    "nctId": "NCT00000004",
    "phase": "2"
  },
  "generalEligibility": [],
  "cohorts": [
    {
      "metadata": {
        "cohortId": "A",
        "evaluable": true,
        "open": true,
        "slotsAvailable": true,
        "blacklist": false,
        "description": "Lung cancer"
      },
      "eligibility": [
        {
          "references": [
            {
              "id": "I-1",
              "text": "Patient is â‰¥18 years of age."
            },
            {
              "id": "I-2",
              "text": "Drug 1 as monotherapy is indicated for the treatment of adults with advanced lung cancer."
            }
          ],
          "function": {
            "rule": "AND",
            "parameters": [
              {
                "rule": "IS_AT_LEAST_X_YEARS_OLD",
                "parameters": [
                  "18"
                ]
              },
              {
                "rule": "OR",
                "parameters": [
                  {
                    "rule": "HAS_LOCALLY_ADVANCED_CANCER",
                    "parameters": []
                  },
                  {
                    "rule": "HAS_METASTATIC_CANCER",
                    "parameters": []
                  }
                ]
              },
              {
                "rule": "HAS_PRIMARY_TUMOR_LOCATION_BELONGING_TO_DOID_TERM_X",
                "parameters": [
                  "Lung cancer"
                ]
              }
            ]
          }
        }
      ]
    }
  ]
}